Chemotherapy Induced Oral Mucositis Market: How Is Palifermin...

добавлена новая статья Health

2026-06-10 06:36:35 -

Chemotherapy Induced Oral Mucositis Market: How Is Palifermin Efficacy Creating Biological Prevention Paradigm?

Palifermin efficacy creating biological prevention — palifermin (Kepivance) — a human keratinocyte growth factor (KGF) recombinant protein — demonstrating efficacy in reducing severe oral mucositis incidence in HSCT patients when administered perioperatively, establishing biological growth factor replacement as a mechanistic approach to OM prevention distinct from symptomatic...

0 Комментарии 0 Поделились 21 Просмотры 0 предпросмотр